← brief for 2026-08-14 · Slowing decline
Case Report: Efficacy and safety of SGLT2 inhibitors in patients with Alström syndrome: a follow-up report of two siblings from the same family.
Key takeaways
This study used-cell models of Alström syndrome to test drug safety. It was not done in humans yet.
Who did this work
Xue B · Li K · Guo Y · Wu Y · Peng H · Fu L · Jiang H
Source
Article · PubMed, the drug frontier · 2026 Jul 30
https://pubmed.ncbi.nlm.nih.gov/42597194/